The National Products Association is urging members to ask California Gov. Gavin Newsom to veto a bill that would place restrictions on the sale of some dietary supplements.
After dominating the UK CBD space with help from a highly engaged online fanbase, CBD beverage, oil and gummy brand Trip is hoping to cement a similar position in the US – but this time with the additional aid of $12m in funding from prominent entrepreneurs...
After a hiatus of over a year, Amazon is again selling NAC-containing dietary supplement products. The development was described as exciting by one industry trade association.
Beans and pulses, considered “neglected staple crops” in many regions of the world, are an important source of resistant starches with gut microbiome-boosting prebiotic potential, says a new review.
An FDA warning letter sent to supplement manufacturer Oregon’s Wild Harvest said the company failed to demonstrate that it had a valid method for assuring that incoming raw material lots were free of contaminants.
New Zealand’s Ministry of Health is intending to regulate natural health products via a self-assessment / declaration process, a move welcomed by the local industry body.
A bipartisan group of US Representatives have sent a letter to House leadership requesting that the dietary supplement provisions be removed from a bill reauthorizing FDA user fees.
Safe Food Advocacy Europe has long been campaigning for an official definition of the term ‘natural’. Yet not all industry players are on board, we are told. How could a legal definition benefit both consumers and the planet?
Legislation currently in the Senate could burden the hemp industry by setting an unrealistically low level of allowable THC, an industry group has said.
The European Specialist Sports Nutrition Alliance (ESSNA) has launched an industry-wide survey to gauge the impact of mandatory front-of-pack nutritional labelling (FOPNL), expected to be introduced across the EU by the end of the year.
A failure on the part of Congress to pass an FDA fee reauthorization bill in a timely fashion could force furloughs among some Agency staff, according a memo from FDA Commissioner Robert Califf.
On Capitol Hill last week, hemp industry stakeholders and Congressional leaders frustrated by FDA’s lack of regulations for CBD and other hemp-derived compounds since the 2018 Farm Bill authorized commercial production of the crop, explored how the 2023...
The FDA appears to be moving ahead with a proposed rule to allow NAC (N-acetyl cysteine) as a dietary ingredient for use in supplements, according to a newly published guidance.
Through research, education, and grants, Realm of Caring is helping those in need of more information about cannabinoid therapies. The non-profit seeks to facilitate and encourage the mainstream acceptance of plant-powered therapies and serve healthcare...
The European Commission (EC) has agreed to amend the conditions of use for novel vitamin B3 ingredient nicotinamide riboside chloride (NR) in foods for special medical purposes and total diet replacement for weight control.
An MLM that sells dietary supplements has been advised to remove claims relating to conditions such as autism, dementia and other disorders from the social media posts managed by distributors.
A new federal agency aimed solely at food safety would be created by a bill introduced recently by US Rep Rosa DeLauro (D-CT) and Sen Dick Durbin (D-IL).
This year’s Dietary Supplement Regulatory Summit in Washington, DC, featured updates and insights from top FDA officials, including the Office of Dietary Supplement Programs along with top stakeholders and industry experts. Here are a few key takeaways...
The dietary supplement industry has reached an unprecedented pinnacle of success. But the industry is facing unforeseen legislative threats, too, unlike any it has faced since the early 1990s.
By Miriam Guggenheim, Partner, Covington & Burling and Steve Mister, President CEO, Council for Responsible Nutrition
Much has been made in recent weeks about the Senate HELP committee’s inclusion in the FDA user fee legislation of a new prohibited act related to dietary supplements. We think this handwringing is sorely misplaced and is creating a false flag to justify...
This year’s NutraIngredients-USA NutraChampion, Rick Kingston, PharmD, presented at the Dietary Supplement Regulatory Summit. The one day event included the five heavy hitters representing the industry: Consumer Healthcare Products Association (CHPA),...
The Council for Responsible Nutrition said that persistent problems with FDA’s NDI Draft Guidance means that few firms likely will file new notifications during the recently announced amnesty window.
A warning letter sent to Young Living, a multi level marketing company specializing in essential oils, underscores the importance of having a social media monitoring program in place to avoid running afoul of regulators.
Australia’s Healthy Care and Canada’s Jamieson Laboratories were the few overseas firms to receive China’s health foods filing approval in the first seven months of 2022, according to a new report.
The US Food and Drug Administration has sent warning letters to four companies marketing sexual enhancement supplements ostensibly based on honey but which contained undeclared ED drugs. The warning letters were part of a ongoing enforcement effort on...
The European Commission has published recommendations that try to clarify the definition of nanomaterials often used in nutrient delivery systems in nanoenabled foods and beverages.
Senator Richard Burr (R-NC), the ranking member of the Senate HELP Committee, has introduced a reauthorization of FDA User Fee Programs which does not include dietary supplement provisions.
The European Commission (EC) is to allow a turmeric-based metabolite on the market as a Novel Food (NF) for 5 years in a move that raises questions about other curcuminoid extracts.
Between Covid-19, supply chain issues and inflation, life is taking a serious toll on mental health. But more and more people are looking for ways to address mental health without a prescription.
FDA and FTC have issued four joint warning letters to kratom companies centered on opioid claims. It’s a move that comes on the heels of FDA rejecting an NDI filing on the ingredient for the sixth time.
An elderberry product marketer has agreed to drop claims that its products contain elderberry in an advertising challenge lodged by Nature’s Way Brands, LLC, which has exposed elderberry adulteration in the past.
NDIs, drug preclusions, the CBD stalemate, actions at the State level, and an impending supply chain nightmare around plastics were just some of the highlights from a recent conference in New York City.
Guidelines that determine the maximum levels of pyrrolizidine alkaloids permitted in dietary supplements take effect this week, in the latest regulatory action that stretches back to 2011.
A bill to place some restrictions on supplement sales in Rhode Island lapsed when the State Legislature went into its summer recess without voting on the measure.
The American Herbal Products Association is urging members and stakeholders to contact lawmakers to oppose the mandatory product listing language that has been attached to a ‘must pass’ fee reauthorization bill.
Proposals to overhaul the UK Cannabidiol (CBD) approval system has led to tension among some members of the Secretariat Advisory Board (SAB) of the All-Party Parliamentary Group (APPG) that liaises with government to inform industry policies.
This year’s International Society of Sports Nutrition Annual Conference & Expo marked its 19th year promoting the science and application of evidence-based sports nutrition and supplementation. NutraIngredients-USA was there to hear about the latest...
Ingredient-specific actions, as evidenced recently by warning letters to 10 firms in the sports nutrition space, are important to FDA’s regulation of dietary supplements but additional actions are hampered by having to deal with problematic ingredients...
The head of the FDA’s Office of Dietary Supplement Programs suspects that remote regulatory assessments (RRAs) will continue even as regular facility inspections resume post-COVID, as the agency seeks to get a good picture of the compliance status of...
A California bill that seeks to place restrictions on the sale of some weight management supplements to minors has passed the State’s Judiciary Committee, and now moves forward to the Senate Appropriations Committee.
Last week’s meeting of the U.S. Food and Drug Administration’s Science Board did little to assuage a frustrated CBD industry that continues to call for regulation of the cannabinoid as a dietary supplement.
Recent amendments to a California bill that seeks to place restrictions on the sale of some weight management supplements to minors removed retail access restrictions and clarifies definitions, leading one trade association to remove its objections.
Mandatory Product Listing can still be a good idea for industry, proponents maintain, even if the latest legislative iteration has failed to garner support from stakeholders.
Three trade organizations joined forces in opposing the FDA Safety and Landmark Advancement Act of 2022 (FDASLA), a fee authorization bill that includes provisions aimed at tightening dietary supplement regulations.
